Skip to main content
رجوع
BLCO logo

Bausch + Lomb Corporation

جودة البيانات: 100%
BLCO
NYSE Healthcare Medical - Instruments & Supplies
KWD 16.02
▲ KWD 0.31 (1.97%)
القيمة السوقية: 5.68B
نطاق اليوم
KWD 15.76 KWD 16.15
نطاق 52 أسبوعًا
KWD 10.45 KWD 18.92
حجم التداول
335,085
متوسط 50 يوم / 200 يوم
KWD 17.19 / KWD 15.41
الإغلاق السابق
KWD 15.71

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -15.8 0.2
P/B 0.9 3.0
ROE % -5.6 3.6
Net Margin % -7.1 3.8
Rev Growth 5Y % 7.9 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 18.90 +18.0%
Low: KWD 16.00 High: KWD 21.00
مكرر الربحية المستقبلي
20.70
ربحية السهم المستقبلية
KWD 0.77
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
5.43B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 1.78
KWD 1.76 – KWD 1.79
 5.93B 1
FY2028 KWD 1.35
KWD 1.04 – KWD 1.58
 6.06B 3
FY2027 KWD 1.05
KWD 0.94 – KWD 1.26
 5.74B 8

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-18 KWD 0.36 KWD 0.32 -9.9%
2025-10-29 KWD 0.16 KWD 0.18 +12.5%
2025-07-30 KWD 0.06 KWD 0.07 +16.7%
2025-04-30 KWD 0.03 -KWD 0.07 -333.3%
2025-02-19 KWD 0.24 KWD 0.25 +4.2%
2024-10-30 KWD 0.16 KWD 0.17 +6.3%
2024-07-31 KWD 0.13 KWD 0.13 0.0%
2024-05-01 KWD 0.09 KWD 0.07 -22.2%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 7.89% annually over 5 years — modest growth
Negative free cash flow of -66.00M
Capital efficient — spends only 6.84% of revenue on capex
ROIC of 1.01% — low return on invested capital
Interest coverage of 0.37× — tight debt servicing

النمو

Revenue Growth (5Y)
7.89%
Revenue (1Y)6.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-5.57%
ROIC1.01%
Net Margin-7.06%
Op. Margin3.12%

الأمان

Debt / Equity
0.83
Current Ratio1.55
Interest Coverage0.37

التقييم

P/E Ratio
-15.77
Forward P/E20.70
P/B Ratio0.88
EV/EBITDA67.06
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6.47% Revenue Growth (3Y) 10.92%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7.89% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.10B Net Income (TTM) -360.00M
ROE -5.57% ROA -2.57%
Gross Margin 58.71% Operating Margin 3.12%
Net Margin -7.06% Free Cash Flow (TTM) -66.00M
ROIC 1.01% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.83 Current Ratio 1.55
Interest Coverage 0.37
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15.77 Forward P/E 20.70
P/B Ratio 0.88 P/S Ratio 1.11
PEG Ratio -1.26 Forward PEG N/A
EV/EBITDA 67.06 Fwd EV/EBITDA 13.80
Forward P/S 1.04 Fwd Earnings Yield 4.83%
FCF Yield -1.16%
Market Cap 5.68B Enterprise Value 10.66B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.10B 4.79B 4.15B 3.77B 3.77B
Net Income -360.00M -317.00M -260.00M 6.00M 182.00M
EPS (Diluted) -1.02 -0.90 -0.74 0.04 0.52
Gross Profit 3.00B 2.92B 2.50B 2.25B 2.30B
Operating Income 159.00M 162.00M 130.00M 207.00M 329.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 14.02B 13.47B 13.44B 11.14B 10.82B
Total Liabilities 7.50B 6.93B 6.52B 4.04B 1.42B
Shareholders' Equity 6.45B 6.47B 6.85B 7.03B 9.33B
Total Debt 5.37B 4.94B 4.68B 2.55B 140.00M
Cash & Equivalents 383.00M 305.00M 334.00M 380.00M 174.00M
Current Assets 2.98B 2.79B 2.74B 2.14B 1.64B
Current Liabilities 1.92B 1.74B 1.58B 1.30B 1.10B